Sign Up Today and Learn More About Ansa Biotechnologies Stock
Invest in or calculate the value of your shares in Ansa Biotechnologies or other pre-IPO companies through EquityZen's platform.
Ansa Biotechnologies Stock
Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.
About Ansa Biotechnologies Stock
Founded
2018
Headquarters
Emeryville, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Ansa Biotechnologies Press Mentions
Stay in the know about the latest news on Ansa Biotechnologies
Ansa Biotechnologies Redefines What’s Possible in DNA Synthesis with 50 kb Sequence-Perfect Clonal Product
businesswire • Oct 23, 2025
Ansa Biotechnologies: $54.4 Million Series B Raised To Transform DNA Synthesis
pulse2 • Oct 09, 2025
Hackers Threaten to Leak 1B Salesforce Records
newsletter • Oct 06, 2025
Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How Scientists Access Synthetic DNA with Industry’s First Guaranteed On-Time Service
synbiobeta • Oct 04, 2025
Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How Scientists Access Synthetic DNA with Industry’s First Guaranteed On-Time Service
biospace • Oct 02, 2025
Ansa Biotechnologies Management
Leadership team at Ansa Biotechnologies
Senior Vice President of Research & Development
Jeremiah Hanes
Board of Director
Yanniv Dorone
Join now and verify your accreditation status to gain access to:
- Ansa Biotechnologies Current Valuation
- Ansa Biotechnologies Stock Price
- Ansa Biotechnologies Management
- Available deals in Ansa Biotechnologies and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ansa Biotechnologies Cap Table and Funding History by Share Class and Liquidity Preferences
- Ansa Biotechnologies Revenue and Financials
- Ansa Biotechnologies Highlights
- Ansa Biotechnologies Business Model
- Ansa Biotechnologies Risk Factors
- Ansa Biotechnologies Research Report from SACRA Research
Trading Ansa Biotechnologies Stock
How to invest in Ansa Biotechnologies stock?
Accredited investors can buy pre-IPO stock in companies like Ansa Biotechnologies through EquityZen funds. These investments are made available by existing Ansa Biotechnologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ansa Biotechnologies stock?
Shareholders can sell their Ansa Biotechnologies stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."